InsidersTradesSigma
Follow the PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025 share price and the full directors' dealings record of the company, a publicly traded company based in Italy. Shares are listed on the IT market, under the authority of Consob. Operating in the Health Care sector, PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025 has logged 0 insider filings. The full history is accessible without an account.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About PHARMANUTRA PHARMANUTRA S.P.A.: CDA APPROVA IL RESOCONTO INTERMEDIO DI GESTIONE AL 30 SETTEMBRE 2025
PHARMANUTRA S.P.A. is a company operating in the health and pharmaceutical sector. It has recently received approval for its interim management report as of September 30, 2025.